Australia's Microba Life Sciences to offer world-first personalised health service

Australian startup Microba Life Sciences has signed a strategic partnership agreement with nib Holdings Limited bac...

May 26, 2022 | Thursday | News
Starpharma's nasal spray effective against influenza A & B virus

Australia-based Starpharma has announced that SPL7013, the antiviral agent in VIRALEZE nasal spray, achieved 95% and 99....

May 23, 2022 | Monday | News
New micro device injects boost to IVF success

A research team led by the University of Adelaide in Australia, in partnership with medical technology company Fertilis,...

May 18, 2022 | Wednesday | News
Scientists closely outsmarting malaria parasites

Researchers from the Australian National University (ANU) have discovered why malaria parasites are vulnerable to s...

May 18, 2022 | Wednesday | News
CSIRO starts work on medicinal psychedelics

Under a new license, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), an Australian Government ...

May 18, 2022 | Wednesday | News
Nanoparticles: sometimes the smallest things can have the biggest impact

Over the last 40 years, technological developments at nano scale have increased interest in nanoparticles and their pote...

May 16, 2022 | Monday | Opinion
ENA Respiratory joins initiative to boost development of antiviral nasal spray

Australia's ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-sp...

May 16, 2022 | Monday | News
Australia launches shared industry vision & blueprint navigating biotech ecosystem

For the first time in 20 years, Australia’s biotechnology sector has united to launch the Biotechnology Blueprint:...

May 16, 2022 | Monday | News
Australia drives medical product development with new initiatives

The University of Western Australia (UWA) and partners will deliver a clinical entrepreneur pilot programme and targeted...

May 13, 2022 | Friday | News
Australia launches first in-human trial for aggressive brain tumours

A novel technology designed to precisely image aggressive brain cancers and guide treatment is being developed by the Un...

May 12, 2022 | Thursday | News
Aravax appoints Dr Brett Haumann to Board of Directors

Australia's Aravax, a clinical stage biotechnology company focused on developing the most advanced novel therapy for pea...

May 11, 2022 | Wednesday | News
Texas Medical Center and Biodesign Australia join hands to enhance healthcare innovation

A major partnership between Texas Medical Center (TMC) and Biodesign Australia has been announced, aimed at advancing he...

May 9, 2022 | Monday | News
Australia develops nanotech imaging tool for smartphone disease diagnosis

Scientists at the University of Melbourne and the Australian Research Council Centre of Excellence for Transformati...

May 6, 2022 | Friday | News
Immuron appoints Steven Lydeamore as Chief Executive Officer

Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeuti...

May 6, 2022 | Friday | News
Ankere Therapeutics launches with AU$10 M seed investment in Australia

A researcher from the Monash Institute of Pharmaceutical Sciences (MIPS) is a co-founder of Australian biotech company, ...

May 6, 2022 | Friday | News
Oz Budget Bolsters Healthcare

The Federal government is committed to its Long Term National Health Plan, through important and strategic inves...

May 6, 2022 | Friday | Analysis
Australia explores use of antidepressants to treat nerve pain

Researchers at Australia’s national science agency Commonwealth Scientific and Industrial Research Organisation (C...

May 5, 2022 | Thursday | News
EMVision partners with Keysight Technologies Australia

Australia's EMVision Medical Devices Limited, a medical device company focused on the development and commercialisation ...

May 5, 2022 | Thursday | News